• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nektar Therapeutics - Common Stock (NQ:NKTR)

    42.97 -1.50 (-3.37%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 474,056
    Open 44.49
    Bid (Size) 42.13 (100)
    Ask (Size) 44.30 (200)
    Prev. Close 44.47
    Today's Range 42.69 - 45.34
    52wk Range 6.480 - 66.92
    Shares Outstanding 183,801,441
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗
    There is a key difference between these two biotechs. 
    Via The Motley Fool
    Topics Bankruptcy

    Performance

    YTD
    -1.0%
    -1.0%
    1 Month
    -25.0%
    -25.0%
    3 Month
    -28.3%
    -28.3%
    6 Month
    +83.1%
    +83.1%
    1 Year
    +144.8%
    +144.8%

    More News

    Read More
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗
    Via The Motley Fool
    News headline image
    Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Top Estimates, Sending Shares Higher ↗
    Via Chartmill
    News headline image
    This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September ↗
    Via The Motley Fool
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing? ↗
    Via The Motley Fool
    News headline image
    Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today ↗
    Via The Motley Fool
    News headline image
    Why Is Nektar Therapeutics Stock Trading Lower On Thursday? ↗
    Via Benzinga
    News headline image
    Why Nektar Therapeutics Rippled Higher This Week ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    What's Going On With Nektar Therapeutics Stock On Thursday? ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday ↗
    Via Benzinga
    News headline image
    Why Nektar Therapeutics Stock Popped 6% on Friday ↗
    Via The Motley Fool
    News headline image
    Nektar (NKTR) Q2 Revenue Falls 52% ↗
    Via The Motley Fool
    News headline image
    3 Bullish Biotech Stocks With Explosive Growth Trends ↗
    Via MarketBeat
    News headline image
    Why Nektar Therapeutics Stock Dived by 3% Today ↗
    Via The Motley Fool
    News headline image
    US Stock Futures Slip After Two Days Of Record Advances: 'FOMO Could Add Another 5%-10%...,' Says Expert ↗
    Via Benzinga
    News headline image
    MSC Industrial Direct, Constellation Brands And 3 Stocks To Watch Heading Into Tuesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Nektar Therapeutics - Common Stock publicly traded?
    Yes, Nektar Therapeutics - Common Stock is publicly traded.
    What exchange does Nektar Therapeutics - Common Stock trade on?
    Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nektar Therapeutics - Common Stock?
    The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
    What is the current price of Nektar Therapeutics - Common Stock?
    The current price of Nektar Therapeutics - Common Stock is 42.97
    When was Nektar Therapeutics - Common Stock last traded?
    The last trade of Nektar Therapeutics - Common Stock was at 01/06/26 04:00 PM ET
    What is the market capitalization of Nektar Therapeutics - Common Stock?
    The market capitalization of Nektar Therapeutics - Common Stock is 7.90B
    How many shares of Nektar Therapeutics - Common Stock are outstanding?
    Nektar Therapeutics - Common Stock has 8B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.